January 18, 2021

On BIOLASE

 

This company just signed a deal that could be a total game-changer. Biolase Inc. (NASDAQ: BIOL) develops, manufactures, markets and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative and complex surgical applications.

The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues, and diode laser systems to perform soft tissue, hygiene, cosmetic procedures and teeth whitening, as well as to provide temporary pain relief. Its Epic Hygiene laser manages nonsurgical periodontitis and enhances clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network.

The company recently announced an agreement with Dental Care Alliance (DCA), one of the largest dental support organizations in the United States, with more than 330 affiliated practices in 20 states, to expand laser adoption and hands-on training programs in targeted geographies. The company expects the agreement to lead to a rollout across all DCA offices in 2021.

Ascendiant Capital Markets has a Buy rating and a $3 price target. The consensus target is $1.41, and shares have been trading near $1.

No comments: